 | | PRD_000402 | | Name: | methoxysuccinyl-alanyl-alanyl-prolyl-alanine chloromethyl ketone | | Formula: | C20 H33 Cl N4 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000406 | | Name: | INHIBITOR ACE-IPA-GLU-GLU-ILE | | Formula: | C29 H40 N4 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000409 | | Name: | MAZ-PY-(ALPHA ME)PY-N-NH2 | | Formula: | C31 H37 N5 O15 P2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000411 | | Name: | N-acetyl-L-alanyl-6-ammonio-N-[(1R)-4-carbamimidamido-1-(dihydroxyboranyl)butyl]-L-norleucinamide | | Formula: | C16 H35 B N7 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000414 | | Name: | Meo-Suc-Ala-Ala-Pro-Val-chloromethyl ketone | | Formula: | C22 H39 Cl N4 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000419 | | Name: | Acetyl-L-alanyl-L-alanyl-L-phenylalanyl-L-alanine chloromethyl ketone, AcAAPACK | | Formula: | C21 H29 Cl N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000421 | | Name: | ACE-PRO-ALA-PRO-PHE-ALDEHYDE | | Formula: | C24 H32 N4 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000422 | | Name: | Ac-Asp-Glu-Val-Asp-Aldehyde | | Formula: | C20 H32 N4 O11 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000423 | | Name: | N-acetyl-L-leucyl-L-alanyl-N-[(1S)-4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]-L-alaninamide | | Formula: | C22 H38 F N5 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000424 | | Name: | ACE-ALA-ALA-PRO-ALA-7-AMINO-4-METHYLCOUMARINN | | Formula: | C25 H31 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000425 | | Name: | Caspase-2 Inhibitor; Ac-VDVAD-Cho | | Formula: | C23 H39 N5 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000427 | | Name: | FIV PROTEASE INHIBITOR LP-149; Ac-NA-Val-Sta-Glu-NA-NH2 | | Formula: | C46 H58 N6 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000429 | | Name: | (ACE)APQV(STA)VMHP peptide Inhibitor | | Formula: | C49 H81 N12 O13 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000430 | | Name: | H 189 | | Formula: | C62 H97 N17 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000431 | | Name: | CASPASE-7 INHIBITOR AC-DMQD-CHO | | Formula: | C20 H33 N5 O10 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000453 | | Name: | N-[3-(1H-benzimidazol-1-yl)propanoyl]glycyl-L-alanyl-L-alaninamide | | Formula: | C18 H24 N6 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000457 | | Name: | INHIBITOR CH2-QLTSNV-Z (SUBSTRATE-ANALOG) | | Formula: | C36 H55 Cl N8 O12 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000480 | | Name: | DECAPEPTIDE HIRUDIN ANALOGUE | | Formula: | C68 H95 N11 O26 S | | Description: | DECAPEPTIDE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000481 | | Name: | N-terminal Asp des-amino Hirudin-3A' | | Formula: | C64 H89 N11 O24 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000483 | | Name: | Bacillomycin Lc | | Formula: | C47 H74 N10 O16 | | Description: | BACILLOMYCIN LC IS A CYCLIC HEPTA-LIPOPETIDE
WITH 7 AMINO-ACIDS OF CONFIGURATION LDDLLDL AND
ONE D-BETA-AMINO CARBOXYLIC ACID.
THE FATTY ACID IS LINKED VIA A PEPTID BOND
TO BOTH RESIDUES 2 AND 8. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000487 | | Name: | Tsushimycin | | Formula: | C59 H93 N13 O20 | | Description: | TSUSHIMYCIN IS A CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) ASP1 N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE RING. RESIDUE 2 AND 11 FORM
A PEPTIDE BOND.
A TETRADECENOIC FATTY ACID IS LINKED TO THE
RESIDUE 1 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000488 | | Name: | TRIOSTIN A | | Formula: | C50 H62 N12 O12 S2 | | Description: | TRIOSTIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A DISULPHIDE BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000491 | | Name: | Echinomycin | | Formula: | C51 H64 N12 O12 S2 | | Description: | ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000492 | | Name: | uk63052 | | Formula: | C56 H68 N10 O14 S2 | | Description: | QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO HYDROXYQUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000504 | | Name: | ADEP2 | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
